Dr.Kaltoom Ali Mohamed Al-Sakkaf PhD MSc BSc
Assistant Professor
Clinical Chemistry

  E-mail :kalsakkaf@kau.edu.sa
                                                                                                  


Publications

Wang Y.A., Johnson, S.K., Brown, B.L. McCarragher L.M., Al-Sakkaf K.A., Royds J.A. and Dobson P.R. (2008).  Enhanced anti-cancer effect of a Phosphatidylinositol-3 kinase inhibitor and doxorubicin on human breast epithelial cell lines with different p53 and oestrogen receptor status.  International Journal of Cancer 123 (7): 1536-1544.

Ruffion L., Al-Sakkaf K.A, Eaton C., Hamdy F.C., Brown, B.L. and Dobson P.R.M. (2003).  The survival Effects of Prolactin on PC3 prostate cancer cells.  European Urology.  43(3):301-308.

Mooney L., Al-Sakkaf K.A., Brown, B.L. and Dobson P.R.M. (2002).  Apoptotic mechanisms in T47D and MCF-7 human breast cancer cells.  British Journal of Cancer 7; 87(8): 909-917.

Al-Sakkaf K.A, Mooney L., Dobson P.R.M. and Brown, B.L. (2000).  Possible role for protein kinase B in the anti-apoptotic effect of prolactin in rat Nb2 lymphoma cells.  Journal of Endocrinology 167, 87-94.

Al-Sakkaf, K.A., Dobson, P.R.M., Brown, B.L. (1997).  Prolactin induced tyrosine phosphorylation of p59fyn may mediate phosphatidylinositol 3-kinase activation in Nb2 cells.  Journal of Molecular Endocrinology 19, 347-350.

Al-Sakkaf, K.A., Dobson, P.R.M., Brown, B.L. (1996).  Activation of phosphatidylinositol 3-kinase by prolactin in Nb2 cells.  Biochemical and Biophysical Research Communications 221[1], 779-784.